Clinical Trial Search

Primary: Number of Correct Responses to Questionnaire Items Immediately Before and After and Educational Lecture — 79; 79; 74; 79 participants

Primary: Global Acne Grading System Score — 32; 30.33; 21.67; 27.5 score on a scale

Primary: Absolute Change in Lesion Counts (Total, Inflammatory, and Non-inflammatory) From Baseline to Week 12 — -16.8; -18.1; -18.9; -18.8 Lesion count — p=0.692

Primary: Mean Change From Baseline to Week 12 in Global Acne Assessment Score (GAAS) — -0.86 score on a scale

Primary: Number of Inflammatory Lesions (Papules and Pustules) — 6; 3; 10; 0 Lesions

Primary: The Change in Number of Facial Inflammatory Acne-related Lesions. — 46; 23.7 Lesions

Primary: Percentage of Participants With Improvement in Acne IGA (Investigator Global Assessment) — 92 percentage of participants

Primary: Mean Change From Baseline in Total Lesion Count — -26.9 Lesions counted

Primary: PGA Score — 0.53 score on a scale

Primary: Percent Change in Truncal Lesion Counts — 52.1; -9.2; 53.2; 18.2 percentage change of lesions

Primary: Patient Perceptions of Their Acne Treatment — 8; 8; 7; 7 score on a scale — p=0.677

Primary: Percentage Change From Baseline (Day 1) of Inflammatory Lesion (IL) Count at Week 4 - Superiority Analysis — -51.9; -38.1 Percent change — p=0.0004

Primary: Absolute Change in Total Lesion Count From Baseline to Week 12 — -55.7; -51.2 Change in lesion count — p=0.002

Primary: Investigator's Global Assessment (IGA) "Success" - Week 12 — 5; 3; 2; 6 Participants

Primary: Success Rate on the Investigator's Global Assessment — 37.9; 21.8; 26.7; 17.9 Percentage of participants